日期: 2025-07-30
代码: 1952.HK
事件: 股东增减持（股东增减持）
TF Capital IV Ltd.于2025-07-30场外减持2256万股，每股均价69.7港元，最新持股数目17.13万股，最新持股比例0.05% @#$ On 25 July 2025, Everest Medicines Limited ("Company"), C-Bridge IV Investment Two Limited ("C-Bridge Two") and the placement agents signed a placing and subscription agreement, pursuant to which C-Bridge Two agreed to sell 22,561,000 shares of the Company to the placees and subscribe for 22,561,000 new shares from the Company. For details, see the announcement of the Company dated 25 July 2025.